期刊文献+

下调CRNDE基因表达对MAPK/ERK通路中相关基因的影响 被引量:3

Effect of down-regulated LncRNA CRNDE expression in MAPK/ERK pathway
下载PDF
导出
摘要 目的 探讨下调LncRNA CRNDE基因表达对MAPK/ERK通路及转录因子中相关基因的影响。方法 将CRNDE基因干扰siRNA 转染人胶质瘤 U251细胞系,并同时设置空白组及对照组,利用实时PCR检测细胞系中MAPK/ERK通路及转录因子中相关基因表达量的变化。结果 与空白组及对照组相比,转染组(si783、si809)中相关基因NF-κB、MEK2、ERK1、ERK2、c-Myc、Raf-1表达量均明显下降(均P <0.05),具有统计学意义。结论 CRNDE可能通过调节MAPK/ERK通路中及转录因子中一系列相关基因表达,增加胶质瘤细胞的增殖和迁移能力,同时抑制细胞凋亡。 Objective To investigate the effect of down-regulated LncRNA CRNDE expression for key kinases and transcription factors in the MAPK/ERK pathway.Methods The LncRNA CRNDE in U251 cells were interfered by using SiRNA.The non-transfected and control group were set up.By Real Time PCR method,the effect of interfering LncRNA CRNDE on U251 cell for key kinases and transcription factors in the MAPK/ERK pathway was observed.Results Compared to the non-transfected group and control group,the expression of the key kinases(Raf-1,MEK2,ERK1,ERK2) and transcription factors(c-Myc,NF-κB) in MAPK/ERK pathway were down-regulated for siRNA group.There were significant differences between non-transfected group,control group and siRNA group(allP<0.05).Conclusion CRNDE can enhance the abilities of cell proliferation and migration,inhibit the ability of cell apoptosis in glioma through activating related gene expression in MAPK/ERK pathway.
作者 邓文月 杜浩 何远志 黄玲玥 路营营 汤伟 景世元 DENG Wen-yue;DU Hao;HE Yuan-zhi(Department of Pediatric Neurosurgery,Wuhan Children's Hospital(Wuhan Maternal and Child Healthcare Hospital),Tongji Medical College,Huazhong University of Science & Technology,Wuhan 430016,China)
出处 《临床神经外科杂志》 CAS 2019年第4期294-297,302,共5页 Journal of Clinical Neurosurgery
基金 武汉市卫生计生科研基金(WX17Q27)
关键词 结直肠癌差异表达长链非编码RNA MAPK/ERK通路 增殖 凋亡 迁移 CRNDE MAPK/ERK pathway proliferation apoptosis migration
  • 相关文献

参考文献1

二级参考文献20

  • 1Qiu M T, Hu J W, Yin R, et al. Long noncoding RNA: an emerging paradigm of cancer research. Tumour Biol, 2013,34 (2) : 613-620.
  • 2Kiang K M, Zhang X Q, Leung G K. Long non-coding RNAs: the key players in glioma pathogenesis. Cancers (Basel), 2015, 7 (3) : 1406-1424.
  • 3Qureshi I A, Mehler M F. Long non-coding RNAs: novel targets for nervous system disease diagnosis and therapy. Neurotherapeutics,2013, 10(4): 632-646.
  • 4Wang K C, Chang H Y. Molecular mechanisms of long noncoding RNAs. Mol Cell, 2011,43(6): 904-914.
  • 5Graham L D, Pedersen S K, Brown G S, et al. Colorectal neoplasia differentially expressed (CRNDE), a novel gene with elevated expression in colorectal adenomas and adenocarcinomas. Genes Cancer, 2011, 2(8) : 829-840.
  • 6Zhang X, Sun S, Pu J K, et al. Long non-coding RNA expression profiles predict clinical phenotypes in glioma. Neurobiol Dis, 2012, 48(1): 1-8.
  • 7Ellis B C, Molloy P L, Graham L D. CRNDE: A long non-coding RNA involved in cancer, neurobiology, and development. Front Genet, 2012, 3: 270-284.
  • 8Khalil A M, Guttman M, Huarte M, et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Prec Natl Acad Sci USA, 2009, 106(28) : 11667-11672.
  • 9Ellis B C, Graham L D, Molloy P L. CRNDE, a long non-coding RNA responsive to insulin/IGF signaling, regulates genes involved in central metabohsm. Biochim Biophys Acta, 2013, 1843 ( 2 ) : 372-386.
  • 10Wang Y, Wang Y, Li J, et al. CRNDE, a long-noncoding RNA, promotes glioma cell growth and invasion through roTOR signaling. Cancer Lett, 2015, 367(2) : 122-128.

共引文献5

同被引文献34

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部